These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27559615)

  • 21. Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice.
    Morita K; Motoyama N; Kitayama T; Morioka N; Kifune K; Dohi T
    J Pharmacol Exp Ther; 2008 Aug; 326(2):633-45. PubMed ID: 18448867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-[2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide: a potent and selective dopamine D4 ligand.
    Perrone R; Berardi F; Colabufo NA; Leopoldo M; Tortorella V
    J Med Chem; 1998 Nov; 41(24):4903-9. PubMed ID: 9822559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The discovery of a structurally novel class of inhibitors of the type 1 glycine transporter.
    Lowe JA; Hou X; Schmidt C; David Tingley F; McHardy S; Kalman M; Deninno S; Sanner M; Ward K; Lebel L; Tunucci D; Valentine J; Bronk BS; Schaeffer E
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2974-6. PubMed ID: 19410451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of N-(2-(azepan-1-yl)-2-phenylethyl)-benzenesulfonamides as novel inhibitors of GlyT1.
    Varnes JG; Forst JM; Hoerter TN; Holmquist CR; Wilkins DE; Tian G; Jonak G; Wang X; Potts WM; Wood MW; Alhambra C; Brugel TA; Albert JS
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4878-81. PubMed ID: 20637614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycine transporter 1 (GlyT1) inhibitors exhibit anticonvulsant properties in the rat maximal electroshock threshold (MEST) test.
    Kalinichev M; Starr KR; Teague S; Bradford AM; Porter RA; Herdon HJ
    Brain Res; 2010 May; 1331():105-13. PubMed ID: 20303337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The discovery of novel N-(2-pyrimidinylamino) benzamide derivatives as potent hedgehog signaling pathway inhibitors.
    Xin M; Wen J; Tang F; Tu C; Shen H; Zhao X
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6777-83. PubMed ID: 24176396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between glycine transporter 1 inhibition as measured with positron emission tomography and changes in cognitive performances in nonhuman primates.
    Castner SA; Murthy NV; Ridler K; Herdon H; Roberts BM; Weinzimmer DP; Huang Y; Zheng MQ; Rabiner EA; Gunn RN; Carson RE; Williams GV; Laruelle M
    Neuropsychopharmacology; 2014 Nov; 39(12):2742-9. PubMed ID: 24487737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological Evidence on Augmented Antiallodynia Following Systemic Co-Treatment with GlyT-1 and GlyT-2 Inhibitors in Rat Neuropathic Pain Model.
    Mohammadzadeh A; Lakatos PP; Balogh M; Zádor F; Karádi DÁ; Zádori ZS; Király K; Galambos AR; Barsi S; Riba P; Benyhe S; Köles L; Tábi T; Szökő É; Harsing LG; Al-Khrasani M
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33804568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive N-methyl-D-aspartate receptor modulation by selective glycine transporter-1 inhibition in the rat dorsal spinal cord in vivo.
    Whitehead KJ; Pearce SM; Walker G; Sundaram H; Hill D; Bowery NG
    Neuroscience; 2004; 126(2):381-90. PubMed ID: 15207356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of the strychnine-sensitive glycine receptor in the anxiolytic effects of GlyT1 inhibitors on maternal separation-induced ultrasonic vocalization in rat pups.
    Komatsu H; Furuya Y; Sawada K; Asada T
    Eur J Pharmacol; 2015 Jan; 746():252-7. PubMed ID: 25435080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery and SAR studies of novel GlyT1 inhibitors.
    Walter MW; Hoffman BJ; Gordon K; Johnson K; Love P; Jones M; Man T; Phebus L; Reel JK; Rudyk HC; Shannon H; Svensson K; Yu H; Valli MJ; Porter WJ
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5233-8. PubMed ID: 17629697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of 1-Methyl-N-(propan-2-yl)-N-({2-[4-(trifluoromethoxy)phenyl]pyridin-4-yl}methyl)-1H-imidazole-4-carboxamide as a Potent and Orally Available Glycine Transporter 1 Inhibitor.
    Yamamoto S; Ohta H; Abe K; Kambe D; Tsukiyama N; Kawakita Y; Moriya M; Yasuhara A
    Chem Pharm Bull (Tokyo); 2016; 64(11):1630-1640. PubMed ID: 27803474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of (4H-1,2,4-triazol-4-yl)isoquinoline derivatives as selective glycine transporter 1 inhibitors.
    Sugane T; Tobe T; Hamaguchi W; Shimada I; Maeno K; Miyata J; Suzuki T; Kimizuka T; Morita T; Sakamoto S; Tsukamoto S
    Bioorg Med Chem; 2012 Jan; 20(1):34-41. PubMed ID: 22177408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of Novel Aminotetralines and Aminochromanes as Selective and Competitive Glycine Transporter 1 (GlyT1) Inhibitors.
    Amberg W; Lange UEW; Ochse M; Pohlki F; Behl B; Relo AL; Hornberger W; Hoft C; Mezler M; Sydor J; Wang Y; Zhao H; Brewer JT; Dietrich J; Li H; Akritopoulou-Zanze I; Lao Y; Hannick SM; Ku YY; Vasudevan A
    J Med Chem; 2018 Sep; 61(17):7503-7524. PubMed ID: 30080045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of 3-Chloro-N-{(S)-[3-(1-ethyl-1H-pyrazol-4-yl)phenyl][(2S)-piperidine-2-yl]methyl}-4-(trifluoromethyl)pyridine-2-carboxamide as a Potent Glycine Transporter 1 Inhibitor.
    Yamamoto S; Shibata T; Abe K; Oda K; Aoki T; Kawakita Y; Kawamoto H
    Chem Pharm Bull (Tokyo); 2016; 64(9):1321-37. PubMed ID: 27581637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and Synthesis of Novel and Selective Glycine Transporter-1 (GlyT1) Inhibitors with Memory Enhancing Properties.
    Santora VJ; Almos TA; Barido R; Basinger J; Bellows CL; Bookser BC; Breitenbucher JG; Broadbent NJ; Cabebe C; Chai CK; Chen M; Chow S; Chung M; Crickard L; Danks AM; Freestone GC; Gitnick D; Gupta V; Hoffmaster C; Hudson AR; Kaplan AP; Kennedy MR; Lee D; Limberis J; Ly K; Mak CC; Masatsugu B; Morse AC; Na J; Neul D; Nikpur J; Peters M; Petroski RE; Renick J; Sebring K; Sevidal S; Tabatabaei A; Wen J; Yan Y; Yoder ZW; Zook D
    J Med Chem; 2018 Jul; 61(14):6018-6033. PubMed ID: 29886732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors.
    Pinard E; Alberati D; Borroni E; Fischer H; Hainzl D; Jolidon S; Moreau JL; Narquizian R; Nettekoven M; Norcross RD; Stalder H; Thomas AW
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5134-9. PubMed ID: 18752953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spinal glycine transporter-1 inhibition influences the micturition reflex in urethane-anesthetized rats.
    Honda M; Hikita K; Kawamoto B; Muraoka K; Shimizu S; Saito M; Sejima T; Chancellor MB; Yoshimura N; Takenaka A
    Int Urol Nephrol; 2016 Mar; 48(3):349-54. PubMed ID: 26843416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.
    Kołaczkowski M; Marcinkowska M; Bucki A; Śniecikowska J; Pawłowski M; Kazek G; Siwek A; Jastrzębska-Więsek M; Partyka A; Wasik A; Wesołowska A; Mierzejewski P; Bienkowski P
    Eur J Med Chem; 2015 Mar; 92():221-35. PubMed ID: 25557493
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.